Peter D. Parker
Peter joined Ampersand in 1988 and served as a General Partner for 18 years. Subsequently, he joined Cequent Pharmaceuticals, an Ampersand portfolio company, as CEO in 2006 before returning to Ampersand as an Advisory Partner in 2011. Prior to joining Ampersand, Peter spent 14 years at AMAX. He holds an M.S. in Chemical Engineering from Columbia.